Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Tomohiro SAWADA"'
Autor:
Haruko Takizawa, Yoshihiko Araki, Maki Fujishiro, Shigeki Tomita, Satsuki Kishikawa, Akane Hashizume, Toru Mitsumori, Hideaki Nitta, Hiroko Iizuka-Honma, Tomohiro Sawada, Mitsuo Okubo, Yasunobu Sekiguchi, Miki Ando, Masaaki Noguchil
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2023, Vol. 63 Issue 2, p83-89, 7p
Publikováno v:
Procedia CIRP. 113:137-142
Autor:
Tomohiro SAWADA, Junichi MATSUMOTO
Publikováno v:
The Proceedings of The Computational Mechanics Conference. :12-06
Autor:
Yasunobu Sekiguchi, Asami Shimada, Moe Matsuzawa, Hidenori Imai, Mutsumi Wakabayashi, Keiji Sugimoto, Noriko Nakamura, Tomohiro Sawada, Junichi Arita, Norio Komatsu, Masaaki Noguchi
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 3, Pp 257-262 (2015)
The patient, a 79-year-old Japanese man, was diagnosed with the chronic phase of chronic myeloid leukemia and begun on nilotinib therapy in April 2011. The therapeutic response was major molecular response in August. About 19 months after the start o
Externí odkaz:
https://doaj.org/article/81f13caacc034b83b8a489532f917c48
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 16; Pages: 4821
Despite the increasing threat of heatstroke with global warming, pathophysiologic injury continues to be defined. In addition, morphological changes of the peripheral blood cells in heatstroke have not been well characterized. We evaluated pathophysi
Autor:
Jungeun Kim, Akihiko Fujiwara, Tomohiro Sawada, Younghun Kim, Kunihisa Sugimoto, Kenichi Kato, Hiroshi Tanaka, Motoyuki Ishikado, Shin-ichi Shamoto, Masaki Takata
Publikováno v:
IUCrJ, Vol 1, Iss 3, Pp 155-159 (2014)
Understanding the nature of superconductivity in iron-based compounds is essential in the development of new strategies to increase Tc. Using a charge density analysis based on synchrotron radiation X-ray powder diffraction data, we found that the ch
Externí odkaz:
https://doaj.org/article/8e112763aa2c4f0daeb1f027bc5c3338
Autor:
Yoshihiko Araki, Naoki Tada, Kenji Yamatoya, Kazunori Miyake, Norio Komatsu, Masaaki Noguchi, Mitsuo Okubo, Tomohiro Sawada, Toshiya Osawa, Yasunobu Sekiguchi, Akimichi Ohsaka, Yuki Nakamura, Yoshiaki Furuta
Publikováno v:
Therapeutic Apheresis and Dialysis. 25:687-696
Plerixafor was introduced to Japan in 2017 as a stem cell mobilization enhancement reagent, but the threshold for its use remains unclear. In this study, we assessed 57 patients treated with plerixafor (33 patients with multiple myeloma (MM) and 24 w
Autor:
Yasuharu Hamano, Tadaaki Inano, Noriko Nakamura, Mitsuo Okubo, Kimihiro Matsumoto, Yasunobu Sekiguchi, Tomohiro Sawada, Masaaki Noguchi, Hiroshi Izumi, Hiroko Iizuka, Mutsumi Wakabayashi, Keiji Sugimoto, Yasutaka Fukuda, Sakura Sakajiri, Shigeki Tomita, Haruko Takizawa, Hiroyuki Isogai
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
A 47-year-old male with macroglossia presented with dyspnea on effort and chest pain at rest. Cardiac MRI revealed diffuse global subendocardial late gadolinium enhancement below the left ventricular endocardium and a dark blood pool of intracardiac
Autor:
Yasunobu, Sekiguchi, Hiroko, Iizuka, Haruko, Takizawa, Toru, Mitsumori, Shigeki, Tomita, Hiroshi, Izumi, Mitsuo, Okubo, Kazunori, Miyake, Toshiya, Osawa, Tomohiro, Sawada, Seiichirou, Yoshikawa, Masaaki, Noguchi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(7)
In Japan, ibrutinib has been approved as both a front-line and later-line treatment for chronic leukemia/small lymphocytic lymphoma(CLL/SLL). However, little is known about the actual outcomes and adverse events(AEs)associated with the use of ibrutin
Autor:
Sakura Sakajiri, Haruko Takizawa, Shigeki Tomita, Yasuharu Hamano, Masaaki Noguchi, Hiroshi Izumi, Hiroko Iizuka, Mitsuo Okubo, Norio Komatsu, Yasutaka Fukuda, Yasunobu Sekiguchi, Tadaaki Inano, Noriko Nakamura, Tomohiro Sawada, Mutsumi Wakabayashi, Keiji Sugimoto
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 60:26-28